Caspase‐3: Structure, function, and biotechnological aspects

Abstract Caspase‐3, a cysteine‐aspartic acid protease, has recently attracted much attention because of its incredible roles in tissue differentiation, regeneration, and neural development. This enzyme is a key zymogen in cell apoptosis and is not activated until it is cleaved by initiator caspases during apoptotic flux. Since caspase‐3 has represented valuable capabilities in the field of medical research, biotechnological aspects of this enzyme, including the production of recombinant type, protein engineering, and designing delivery systems, have been considered as emerging therapeutic strategies in treating the apoptosis‐related disorders. To date, several advances have been made in the therapeutic use of caspase‐3 in the management of some diseases such as cancers, heart failure, and neurodegenerative disorders. In the current review, we intend to discuss the caspase‐3's structure, functions, therapeutic applications, as well as its molecular cloning, protein engineering, and relevant delivery systems.